In November 2025, China issued a revised version of its Patent Examination Guidelines, which took effect on January 1 2026. The revision introduces significant changes to the examination standards for patent applications in the field of biological breedin...

In recent years, China has emerged as a significant global player in the pharmaceutical sector, not only due to its vast market potential but also because of its evolving intellectual property (IP) framework. To further encourage innovation in life scienc...

A Practice Note addressing the final remedies available in patent infringement litigation under the laws of China. This Note is part of a global suite of jurisdiction-specific resources helping in-house lawyers and private practice attorneys navigate eac...

China has developed rapidly in the pharmaceutical industry in the past few years and has become one of the largest and most active pharmaceutical markets in the world. To further encourage innovation in drug development, China has initiated a series of re...